Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Engle · SciRah

Researcher profile · Semantic Scholar

M. Engle

Share profile

M. Engle — researcher profile on SciRah

h-index: 17
Works: 29
Citations: 1,610

Most-cited papers

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
S. Dorman, Payam Nahid, E. Kurbatova, P. Phillips +27 more
2021New England Journal of Medicine374 citations Open access
Semantic Scholar
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
W. Burman, S. Goldberg, J. E. Johnson, Grace Muzanye +8 more
2006American Journal of Respiratory and Critical Care Medicine263 citations
Semantic Scholar
Effects of Tuberculosis, Race, and Human Gene SLCO1B1 Polymorphisms on Rifampin Concentrations
M. Weiner, C. Peloquin, W. Burman, Chi-Cheng Luo +6 more
2010Antimicrobial Agents and Chemotherapy154 citations Open access
Semantic Scholar
Effects of Rifampin and Multidrug Resistance Gene Polymorphism on Concentrations of Moxifloxacin
M. Weiner, W. Burman, Chi-Cheng Luo, C. Peloquin +4 more
2007Antimicrobial Agents and Chemotherapy109 citations Open access
Semantic Scholar
Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers.
M. Weiner, E. Egelund, M. Engle, M. Kiser +4 more
2014Journal of Antimicrobial Chemotherapy98 citations Open access
Semantic Scholar
Defining the Optimal Dose of Rifapentine for Pulmonary Tuberculosis: Exposure-Response Relations From Two Phase 2 Clinical Trials
R. Savic, M. Weiner, W. Mac Kenzie, M. Engle +8 more
2017Clinical pharmacology and therapy71 citations Open access
Semantic Scholar
Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial.
A. Anzueto, Amal Jubran, J. Ohar, C. Piquette +7 more
1998Journal of the American Medical Association (JAMA)63 citations
Semantic Scholar
Aptamer-based Proteomic Signature of Intensive Phase Treatment Response in Pulmonary Tuberculosis
Payam Nahid, Erin Bliven-Sizemore, Leah Jarlsberg, A. Mary +8 more
2014Tuberculosis62 citations Open access
Semantic Scholar
Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosis.
M. Weiner, D. Benator, C. Peloquin, W. Burman +4 more
2005Clinical Infectious Diseases61 citations
Semantic Scholar
Effects of Aerosolized Surfactant in Patients With Stable Chronic Bronchitis: A Prospective Randomized Controlled Trial
A. Anzueto, A. Jubran, J. Ohar, C. Piquette +7 more
199758 citations
Semantic Scholar
Blood Transcriptional Biomarkers for Active Tuberculosis among Patients in the United States: a Case-Control Study with Systematic Cross-Classifier Evaluation
Nicholas D. Walter, Mikaela A. Miller, J. Vásquez, M. Weiner +19 more
2015Journal of Clinical Microbiology56 citations Open access
Semantic Scholar
Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection.
M. Weiner, R. Savic, William R. Mac Kenzie, Diane Wing +11 more
2014Journal of the Pediatric Infectious Diseases Society44 citations
Semantic Scholar
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: study protocol for TBTC Study 31/ACTG A5349 phase 3 clinical trial
S. Dorman, Payam Nahid, E. Kurbatova, S. Goldberg +28 more
2020Contemporary Clinical Trials40 citations Open access
Semantic Scholar
Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis
A. Jayakumar, E. Vittinghoff, M. Segal, W. Mackenzie +9 more
2015Tuberculosis34 citations Open access
Semantic Scholar
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
Vincent K. Chang, M. Imperial, P. Phillips, G. E. Velásquez +20 more
2024Nature Communications27 citations Open access
Semantic Scholar
Evaluation of Time to Detection of Mycobacterium tuberculosis in Broth Culture as a Determinant for End Points in Treatment Trials
M. Weiner, T. Prihoda, W. Burman, J. E. Johnson +7 more
2010Journal of Clinical Microbiology18 citations Open access
Semantic Scholar
Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis.
M. Weiner, J. Gelfond, T. Johnson-Pais, M. Engle +6 more
2020Journal of Antimicrobial Chemotherapy17 citations Open access
Semantic Scholar
Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.−11187G>A Polymorphism in Adults with Pulmonary Tuberculosis
M. Weiner, J. Gelfond, T. Johnson-Pais, M. Engle +4 more
2018Antimicrobial Agents and Chemotherapy17 citations Open access
Semantic Scholar
Clinical Evaluation of the Nelfinavir‐Rifabutin Interaction in Patients with Tuberculosis and Human Immunodeficiency Virus Infection
D. Benator, M. Weiner, W. Burman, A. Vernon +9 more
2007Pharmacotherapy14 citations
Semantic Scholar
Reasons for non-participation in an international multicenter trial of a new drug for tuberculosis treatment.
D. Lamunu, K. N. Chapman, P. Nsubuga, G. Muzanyi +9 more
2012The International Journal of Tuberculosis and Lung Disease9 citations Open access
Semantic Scholar
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial
Ava Y. Xu, G. E. Velásquez, Nan Zhang, Vincent K. Chang +17 more
2024American Journal of Respiratory and Critical Care Medicine7 citations Open access
Semantic Scholar
Central Monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis
Kia Bryant, Yan Yuan, M. Engle, E. Kurbatova +18 more
2021Contemporary Clinical Trials5 citations Open access
Semantic Scholar
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
E. Kurbatova, William C. Whitworth, L. Peddareddy, P. Phillips +16 more
2025Emerging Infectious Diseases4 citations Open access
Semantic Scholar
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis
Huy X Ngo, Ava Y. Xu, G. Velásquez, Nan Zhang +17 more
2024Clinical Infectious Diseases4 citations Open access
Semantic Scholar
Rifapentine Exposure In A Trial Of Daily Rifapentine Compared To Rifampin During The Intensive Phase Of TB Treatment
M. Weiner, C. Peloquin, E. Egelund, M. Engle +7 more
2011Asian Test Symposium3 citations
Semantic Scholar
Ethambutol Population Pharmacokinetics and Pharmacodynamics from a Phase 3 Confirmatory Trial for the Treatment of Tuberculosis
S. Alkhafaji, E. Yang, Kaylee Lee, Vincent K. Chang +15 more
2026Journal of Infectious Diseases0 citations Open access
Semantic Scholar
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
Vincent K. Chang, Marjorie Imperial, P. Phillips, G. E. Velásquez +22 more
2025Nature Communications0 citations Open access
Semantic Scholar
Effects of Rifampin and Multidrug Resistance Gene Polymorphism on Concentrations of Moxiﬂoxacin (cid:1)
M. Weiner, W. Burman, Chi-Cheng Luo, C. Peloquin +4 more
20070 citations
Semantic Scholar
1431 PULMONARY FUNCTION AFTER IV INDOMETHACIN IN PRETERM INFANTS
A. Krauss, N. Fatica, B. Lewis, R. Cooper +4 more
1985Pediatric Research0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Weiner×15
Invite
M. Weiner — researcher profile on SciRah
Payam Nahid×10
Invite
Payam Nahid — researcher profile on SciRah
W. Burman×10
Invite
W. Burman — researcher profile on SciRah
J. E. Johnson×9
Invite
J. E. Johnson — researcher profile on SciRah

×9

Invite

E. Sizemore — researcher profile on SciRah

Invite

R. Chaisson — researcher profile on SciRah

Invite

Kia Bryant — researcher profile on SciRah

Invite

R. Savic — researcher profile on SciRah

Invite

C. Peloquin — researcher profile on SciRah

Invite

P. Nsubuga — researcher profile on SciRah

Invite

S. Goldberg — researcher profile on SciRah

Invite

A. Vernon — researcher profile on SciRah